“…For instance, [V(ma) 2 (N-N)][ClO 4 ] (N-N = bpy, phen, dpq, dppz) and vanadium(V) complexes bearing aspartic-b-and glutamic-g-hydroxamic acid as ligands, were examined for insulin mimetic activity. 76,77 The antidiabetic characteristics of [VO(dmpp) 2 ], [VO(pimin) 2 ], [VO(Etpimin) 2 ] and [VO(EtOHpimin) 2 ] were assessed (dmpp = bis(1,2-dimethyl-3-hydroxy-4pyridinonate), piminH = 2-(2 0 -hydroxyphenyl)-1H-imidazoline, EtpiminH = 2-(2 0 -hydroxyphenyl)-1-ethylimidazoline, EtOHpimin = 2-(2 0 -hydroxyphenyl)-1-ethanolimidazoline). 78,79 The biotransformation of insulin-enhancing vanadium complexes, [VO(6-mepci) 2 ], [cis-{VO(pic) 2 (H 2 O)], [VO(acac) 2 ] and [VO(dhp) 2 ], were examined (6-mepci-H = 6-methylpicolinic acid, dhp-H = 1,2-dimethyl-3-hydroxy-4(1H)-pyridinone).…”